Lv1
30 积分 2025-07-27 加入
Patient and public involvement in research reporting
1天前
求助中
Putting patients first in medicines regulation?
1天前
求助中
Process and strategies for patient engagement and outreach in the Sickle Cell Disease (SCD) community to promote clinical trial participation
13天前
已完结
基于毒理学数据库整合有害结局路径(AOP)分析的 有机磷酸酯毒性及机制研究
24天前
已关闭
Algorithm for identifying chemotherapy/biological regimens for metastatic colon cancer in SEER-Medicare
1个月前
已完结
Drug Review and Approval Policies Based on Real-world Evidence in China and the United States: A Comparative Study
2个月前
已完结
Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial
2个月前
已完结
Atezolizumab in combination with carboplatin plus nab-paclitaxel chemotherapy compared with chemotherapy alone as first-line treatment for metastatic non-squamous non-small-cell lung cancer (IMpower130): a multicentre, randomised, open-label, phase 3 trial
2个月前
已完结
Alectinib versus crizotinib in patients with ALK-positive non-small-cell lung cancer (J-ALEX): an open-label, randomised phase 3 trial
2个月前
已完结
Afatinib versus erlotinib as second-line treatment of patients with advanced squamous cell carcinoma of the lung (LUX-lung 8): An open-label randomised controlled phase 3 trial
2个月前
已完结
皖公网安备34019202002308
